Interaction Propensity
Strongest directed Tier 1 cell-ontology contact preference per sample. Bulk files are centralized on the Download page.
201-250 of 2,070
Interaction Propensity
Strongest directed Tier 1 cell-ontology contact preference per sample.
2,069 ready
| Sample | Organ | Disease state | Cells | Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. | Direction | Propensity | FDR |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B5,1 | Lung | Primary cancer | 5,849 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.27 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B5,10 | Lung | Primary cancer | 3,111 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.17 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B5,11 | Lung | Primary cancer | 3,572 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.44 | 1.58e-2 |
| NSCLC_38242124__IMC__175_B5,12 | Lung | Primary cancer | 3,967 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.30 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B5,13 | Lung | Primary cancer | 2,364 | Stromal -> Stromal | Enriched | 4.20 | 1.98e-2 |
| NSCLC_38242124__IMC__175_B5,14 | Lung | Primary cancer | 3,391 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.39 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B5,15 | Lung | Primary cancer | 2,515 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.40 | 1.44e-2 |
| NSCLC_38242124__IMC__175_B5,16 | Lung | Primary cancer | 2,891 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.62 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B5,17 | Lung | Primary cancer | 3,442 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.69 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B5,2 | Lung | Primary cancer | 3,313 | Other -> Other | Enriched | 4.37 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B5,3 | Lung | Primary cancer | 3,516 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.40 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B5,4 | Lung | Primary cancer | 3,890 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.11 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B5,5 | Lung | Primary cancer | 3,985 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.59 | 1.44e-2 |
| NSCLC_38242124__IMC__175_B5,6 | Lung | Primary cancer | 3,188 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.83 | 1.44e-2 |
| NSCLC_38242124__IMC__175_B5,7 | Lung | Primary cancer | 3,997 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.23 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B5,8 | Lung | Primary cancer | 2,196 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.69 | 1.76e-2 |
| NSCLC_38242124__IMC__175_B5,9 | Lung | Primary cancer | 3,264 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.23 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B6,1 | Lung | Primary cancer | 5,482 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.59 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B6,10 | Lung | Primary cancer | 3,587 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.22 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B6,11 | Lung | Primary cancer | 3,189 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.66 | 1.58e-2 |
| NSCLC_38242124__IMC__175_B6,12 | Lung | Primary cancer | 3,515 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.59 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B6,13 | Lung | Primary cancer | 1,900 | Stromal -> Stromal | Enriched | 4.43 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B6,14 | Lung | Primary cancer | 3,094 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.42 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B6,15 | Lung | Primary cancer | 2,936 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.53 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B6,16 | Lung | Primary cancer | 2,433 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.93 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B6,17 | Lung | Primary cancer | 3,239 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.94 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B6,2 | Lung | Primary cancer | 2,696 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.03 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B6,3 | Lung | Primary cancer | 3,549 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.26 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B6,4 | Lung | Primary cancer | 1,915 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.44 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B6,5 | Lung | Primary cancer | 2,363 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.72 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B6,6 | Lung | Primary cancer | 2,579 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.75 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B6,7 | Lung | Primary cancer | 3,749 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.35 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B6,8 | Lung | Primary cancer | 2,866 | Stromal -> Stromal | Enriched | 4.18 | 1.58e-2 |
| NSCLC_38242124__IMC__175_B6,9 | Lung | Primary cancer | 5,561 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.53 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B7,1 | Lung | Primary cancer | 823 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.98 | 1.58e-2 |
| NSCLC_38242124__IMC__175_B7,10 | Lung | Primary cancer | 3,104 | Stromal -> Stromal | Enriched | 4.49 | 1.58e-2 |
| NSCLC_38242124__IMC__175_B7,11 | Lung | Primary cancer | 3,417 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.10 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B7,12 | Lung | Primary cancer | 3,705 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.60 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B7,13 | Lung | Primary cancer | 3,302 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.71 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B7,14 | Lung | Primary cancer | 3,561 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.53 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B7,15 | Lung | Primary cancer | 5,889 | Immune -> Immune | Enriched | 5.79 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B7,16 | Lung | Primary cancer | 3,895 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.09 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B7,17 | Lung | Primary cancer | 2,340 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.63 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B7,2 | Lung | Primary cancer | 3,451 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.06 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B7,3 | Lung | Primary cancer | 2,129 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.20 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B7,4 | Lung | Primary cancer | 1,543 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.89 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B7,5 | Lung | Primary cancer | 2,916 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.28 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B7,6 | Lung | Primary cancer | 3,524 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.56 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B7,7 | Lung | Primary cancer | 3,227 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.39 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B7,8 | Lung | Primary cancer | 3,567 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.21 | 9.90e-3 |